Compare Abeona Therapeutics Inc (ABEO) vs Marathon Digital Holdings Inc (MARA) Price & Performance

ABEO trades at $7.365, down 1.14% today, amid a bullish technical outlook with moving averages signaling strength. The company reported a net income of $71.18 million in 2025, with a net margin of 454.86%, though revenue remains modest at $5.82 million. Recent news includes CMS granting NTAP status for ZEVASKYN and expanding its treatment center network, indicating commercial progress.

The outlook is supported by strong analyst consensus (66.7% buy ratings) and robust profitability metrics, but risks include high SG&A expenses relative to revenue and a shareholder investigation. Upside hinges on revenue scaling to justify current valuations, with the Q2 2026 earnings call on August 13, 2026, as a key near-term catalyst.

Marathon Digital Holdings (MARA) trades at $9.95, up 4.08% today but remains under pressure with a bearish technical signal. The company reported a Q2 2026 net loss of $1.60 per share, missing estimates, as revenue fell to $804 million with a net income margin of -429.71%. Despite negative cash flow from operations, MARA is pivoting toward AI digital infrastructure, appointing new directors to support growth. Analyst consensus is mixed with a $16.08 price target but high volatility persists.

MARA's outlook is challenged by persistent losses and high execution risk in its strategic shift, though its low P/E of 3.37 suggests deep value if the AI pivot succeeds. Key risks include Bitcoin price sensitivity, competitive pressures, and cash burn. Investors should weigh the 50% buy rating against fundamental weaknesses before considering a position.